Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-03 to 2023-02-27
Current total value of award: $1950.6
Description: 4559985191!OZURDEX 0.7 MG IMPLANTS